Phillip A. Morton

1.2k total citations
19 papers, 999 citations indexed

About

Phillip A. Morton is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Phillip A. Morton has authored 19 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Hematology. Recurrent topics in Phillip A. Morton's work include T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Phillip A. Morton is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Phillip A. Morton collaborates with scholars based in United States, Japan and Germany. Phillip A. Morton's co-authors include Alan L. Schwartz, D. Owensby, Robert W. Karr, Marc K. Jenkins, Dennis Y. Loh, Jeffrey A. Bluestone, Theresa L. Walunas, K S Giacoletto, Guojun Bu and Tze-Chein Wun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Phillip A. Morton

19 papers receiving 978 citations

Peers

Countries citing papers authored by Phillip A. Morton

Since Specialization

Citations

This map shows the geographic impact of Phillip A. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip A. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip A. Morton more than expected).

Fields of papers citing papers by Phillip A. Morton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip A. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip A. Morton. The network helps show where Phillip A. Morton may publish in the future.

Co-authorship network of co-authors of Phillip A. Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip A. Morton. A scholar is included among the top collaborators of Phillip A. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip A. Morton. Phillip A. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	In vivo imaging implicates CCR2+ monocytes as regulators of neutrophil recruitment during arthritis 2012 ·Cellular Immunology ·Baomei Wang, Bernd H. Zinselmeyer, Herbert A. Runnels, Timothy P. LaBranche, Phillip A. Morton, Daniel Kreisel, Matthias Mack, Cheryl Nickerson‐Nutter, Paul M. Allen, Mark J. Miller	27
2	Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studies 2010 ·Advances in Therapy ·Herbert A. Runnels, (unknown), (unknown), (unknown), (unknown), (unknown), Debra M. Meyer, Michelle Evans, Christine P. Bono, Wen‐Rong Lie, Mark Moffat, Gerald F. Casperson, Simon Lennard, John Elvin, Tristan J. Vaughan, Christine E. Smith, Phillip A. Morton	5
3	A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-γ and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery 2002 ·The Journal of Immunology ·Jeff Alexander, Carla Oseroff, Carol Dahlberg, (unknown), Glenn Ishioka, (unknown), John Fikes, Mark J. Newman, Robert W. Chesnut, Phillip A. Morton, Kam F. Fok, Ettore Appella, Alessandro Sette	52
4	Mice Deficient in Perforin, CD4⁺T Cells, or CD28-Mediated Signaling Maintain the Typical Immunodominance Hierarchies of CD8⁺T-Cell Responses to Influenza Virus 2002 ·Journal of Virology ·Weisan Chen, Jack R. Bennink, Phillip A. Morton, Jonathan W. Yewdell	48
5	Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. 2001 ·PubMed ·Hui Shao, (unknown), Satoshi Nakamura, (unknown), Phillip A. Morton, Nalini S. Bora, Henry J. Kaplan	19
6	Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals 1998 ·Proceedings of the National Academy of Sciences ·Sung-Kwon Kim, Douglas S. Reed, Sara Olson, Matthias J. Schnell, John K. Rose, Phillip A. Morton, Leo Lefrançois	109
7	The biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts. 1996 ·The Journal of Cell Biology ·Jonathan N. Glickman, Phillip A. Morton, Jan W. Slot, Stuart Kornfeld, Hans J. Geuze	67
8	Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2) 1996 ·The Journal of Immunology ·Phillip A. Morton, (unknown), James A. Stewart, K S Giacoletto, (unknown), Clinton E. Leysath, R J Evans, James J. Shieh, Robert W. Karr	67
9	Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4 1995 ·The Journal of Immunology ·(unknown), Theresa L. Walunas, Robert W. Karr, Phillip A. Morton, Dennis Y. Loh, Jeffrey A. Bluestone, Marc K. Jenkins	274
10	Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. 1995 ·The Journal of Immunology ·Phillip A. Morton, (unknown), K S Giacoletto, Jantina Manning, Brett D. Schwartz	75
11	Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor. 1992 ·Journal of Biological Chemistry ·Guojun Bu, Phillip A. Morton, Alan L. Schwartz	64
12	Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. 1991 ·Journal of Biological Chemistry ·D. Owensby, Phillip A. Morton, Tze-Chein Wun, Alan L. Schwartz	40
13	Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells. 1990 ·Journal of Biological Chemistry ·Phillip A. Morton, D. Owensby, Tze-Chein Wun, Joseph J. Billadello, Alan L. Schwartz	35
14	Chapter 12 Quantitative Evaluation of Receptor-Mediated Endocytosis 1989 ·Methods in cell biology ·D. Owensby, Phillip A. Morton, Alan L. Schwartz	14
15	Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2 1989 ·Journal of Biological Chemistry ·Phillip A. Morton, D. Owensby, Burton E. Sobel, Alan L. Schwartz	49
16	Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2 1989 ·Journal of Biological Chemistry ·D. Owensby, Phillip A. Morton, Alan L. Schwartz	45
17	Extracellular and cellular proteins of rat cells with O-glycosidically linked fucose 1985 ·Biochemical Journal ·Phillip A. Morton, Sheldon M. Steiner	4
18	Metabolism of a transformation-sensitive amino acid fucoside in normal and simian virus 40-transformed human embryonic lung cells. 1984 ·PubMed ·Sheldon M. Steiner, Phillip A. Morton	1
19	Characterization of an amino acid fucoside of normal and SV40-transformed human embryonic lung cells. 1982 ·PubMed ·Phillip A. Morton, M Klinger, Sheldon M. Steiner	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact